Medical

central retinal vein

Also found in: Acronyms, Wikipedia.

cen·tral retinal vein

[TA]
the vein, formed by union of the retinal veins; accompanies the artery of the same name in the optic nerve.
Synonym(s): vena centralis retinae [TA]
Farlex Partner Medical Dictionary © Farlex 2012

Central retinal vein

Central blood vessel and its branches that drains the retina.
Mentioned in: Retinal Vein Occlusion
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.
Mentioned in
References in periodicals archive
Thrombophilic risk factors in patients with central retinal vein occlusion.
Genetic correlation between Prothrombin G20210A polymorphism and retinal vein occlusion risk
Conclusion: Radial optic neurotomy improved both the visual function and macular edema in ischemic central retinal vein occlusion.
EFFECTIVENESS OF RADIAL OPTIC NEUROTOMY FOR ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION
Conforto, "The Natural Course of Central Retinal Vein Occlusion" Ophthalmology, vol.
Sequential Observations of Conversion from Nonischemic to Ischemic Central Retinal Vein Occlusion Using Optical Coherence Tomography Angiography
Ho et al., "Therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology," Ophthalmology, vol.
Deep Neural Network-Based Method for Detecting Central Retinal Vein Occlusion Using Ultrawide-Field Fundus Ophthalmoscopy
Late hyperbaric oxygen treatment of cilioretinal artery occlusion with nonischemic central retinal vein occlusion secondary to high altitude.
Visual outcome of retinal vein occlusion in patients residing at high altitude
Azad, "Case report: bilateral simultaneous central retinal vein occlusion in Waldenstroom's macroglobulinemia," Optometry, vol.
Waldenstrom's Macroglobulinemia: A Report of Two Cases, One with Severe Retinopathy and One with Renal Failure
* Central retinal vein occlusion (CRVO) has various etiologies, mostly because of hypercoagulopathies or cardiovascular diseases.
Sulfur mustard exposure and non-ischemic central retinal vein occlusion
Specifically designed for the eye and proven to save sight, ranibizumab is indicated for the treatment of neovascular wet age-related macular degeneration (wet AMD), visual impairment due to DME and due to macular edema secondary to both branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO); and visual impairment due to choroidal neovascularization (CNV) secondary to pathologic myopia (myopic CNV).
Novartis partners with local diabetes and eye specialists
Outside the U.S., Lucentis is approved in more than 100 countries to treat patients with wet AMD, for the treatment of DME, and due to macular edema secondary to both branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO).
FDA approves Roche's Lucentis (ranibizumab injection) for treatment of diabetic retinopathy in people with diabetic macular edema
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.